Skip to main content
SpringerLink
Log in

Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Flemming JA, Zhang-Salomons J, Nanji S, et al. Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: a population-based study. Cancer. 2016;122(16):2534-2543.

  2. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273-1281.

  3. Shroff RT, Javle MM, Xiao L, et al. Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial. JAMA Oncol. 2019;5(6):824-830.

  4. Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Res. 1978;38(11 Pt 1):3784-92.

  5. Jarnagin WR, Schwartz LH, Gultekin DH, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol. 2009;20(9):1589-1595.

  6. Cercek A, Boerner T, Tan BR, et al. Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2020;6(1):60-67.

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Alexander J. Rossi MD, Tahsin M. Khan MD, Allen J. Luna BE & Jonathan M. Hernandez MD

  2. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Andrea Cercek MD & William R. Jarnagin MD

Authors
  1. Alexander J. Rossi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tahsin M. Khan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Allen J. Luna BE
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrea Cercek MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William R. Jarnagin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to William R. Jarnagin MD or Jonathan M. Hernandez MD.

Ethics declarations

Disclosure

The authors declare they have no conflicts of interest and nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 181 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rossi, A.J., Khan, T.M., Luna, A.J. et al. Hepatic Artery Infusion Pump (HAIP) Therapy Versus Chemotherapy in the First-Line Setting for Patients with Unresectable Intrahepatic Cholangiocarcinoma. Ann Surg Oncol 29, 35–36 (2022). https://doi.org/10.1245/s10434-021-10279-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10279-5

Search

Navigation